Related Experiment Video
Updated: Jun 22, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Multifaceted roles and functions of SOX30 in human cancer
Na Sun1, Cheng Wang1, Pingping Gao1
1Department of Breast and Thyroid Surgery The Southwest Hospital of Army Medical University Chongqing China.
Abstract:
SRY-box transcription factor 30 (SOX30) participates in tumor cell apoptosis in lung cancer. The occurrence of somatic SOX30 mutations, the expression signature of SOX30 in normal and cancer tissues, the correlation of SOX30 with immune cells and immune-related genes, and the clinical significance of SOX30 in various cancers have stimulated interest in SOX30 as a potential cancer biomarker. SOX30 influences drug sensitivity and tumor immunity in specific cancer types. In this review, we have comprehensively summarized the latest research on the role of SOX30 in cancer by combining bioinformatics evidence and a literature review. We summarize recent research on SOX30 in cancer regarding somatic mutations, trials, transcriptome analysis, clinical information, and SOX30-mediated regulation of malignant phenotypes. Additionally, we report on the diagnostic value of SOX30 mRNA expression levels across different cancer types. This review on the role of SOX30 in cancer progression may provide insights into possible research directions for SOX30 in cancer and a theoretical basis for guiding future studies.
Insights
SRY-box transcription factor 30 (SOX30) is crucial for lung cancer cell apoptosis. This review explores SOX30's role in various cancers, highlighting its potential as a diagnostic biomarker and its influence on tumor immunity and drug sensitivity.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- SRY-box transcription factor 30 (SOX30) is implicated in lung cancer cell apoptosis.
- Growing evidence suggests SOX30's involvement in diverse cancer types, prompting investigation into its biomarker potential.
Purpose of the Study:
- To comprehensively review the latest research on SOX30's role in cancer progression.
- To consolidate findings on SOX30 mutations, expression, clinical significance, and its impact on tumor immunity and drug sensitivity.
Main Methods:
- Literature review and bioinformatics analysis.
- Examination of somatic mutations, gene expression signatures, and clinical data related to SOX30.
- Correlation analysis of SOX30 with immune cells and genes.
Main Results:
- SOX30 plays a role in tumor cell apoptosis and influences drug sensitivity and tumor immunity in specific cancers.
- SOX30 exhibits distinct expression patterns in normal versus cancer tissues.
- SOX30 mRNA expression levels show diagnostic value across various cancer types.
Conclusions:
- SOX30 is a promising candidate for cancer biomarker development.
- Further research into SOX30's mechanisms in cancer progression is warranted.
- This review provides a theoretical basis for future SOX30-focused cancer studies.
More Related Videos
08:29SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
09:58An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
Related Concept Videos
Pleiotropy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...